Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Madrigal Stock Soars 11% After FDA Approved The First MASH Treatment

After a bumpy road, Madrigal gained FDA approval for the first-ever MASH treatment, Rezdiffra, and Madrigal stock skyrocketed.

Investors Business Daily

Most US sandwich baggies contain toxic PFAS ‘forever chemicals’, analysis says

Testing commissioned by Mamavation blog found high levels of a marker of PFAS in nine of 11 baggies tested

The Guardian - US

1 AI Growth Stock With 54% Upside Potential

Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered investments from both AI chipmaker Nvidia and ARKK fund manager Cathie Wood.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Here are the concerns with artificial food dyes, as California weighs a ban in schools

Six artificial food dyes and titanium dioxide would be banned in schools under a proposal in the state legislature. Critics say there isn't enough evidence to prove they're a health risk.

WEKU

A simple blood test can detect colorectal cancer early, study finds

At a time when colorectal cancer is rising, researchers say a blood test can detect 83% of people with the disease. If the FDA approves it the test would be another screening tool for early detection.

WEKU

Growing teen THC use could further complicate cannabis policy - Roll Call

Adolescents are using an often unregulated, psychoactive derivative of cannabis, according to national data released Wednesday.

Roll Call

Abortion Pill Studies Retracted: Politics or Science?

"Following the science" as the Supreme Court considers the safety and efficacy of medical abortions.

Reason

Read news from The Economist, FT, and more,
with one subscription

COVID patients can't get Paxlovid

The price is one reason Paxlovid is not reaching those who need it most

Salon

Why covid patients who could most benefit from paxlovid still aren’t getting it

During the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.

The Texas Tribune

Civil servants threaten ministers with legal action over Rwanda bill

Union says Home Office staff could be in breach of international law if they implement deportations

The Guardian - UK

Federal courts seek to stop ‘judge shopping’ with new rule - Roll Call

The federal judiciary announced a new rule Tuesday on how cases are assigned to judges to discourage so-called “judge shopping” nationwide.

Roll Call

There's a new prescription pill for postpartum depression. How will coverage work?

A prescription pill to treat postpartum depression hit the market in December, but most insurers do not yet have a policy on how patients can access it or when they will pay for it.

WEKU

AirPods Pro could double as hearing aids after this rumored iOS 18 update

Your AirPods Pro might be getting a "major new hearing aid mode" with the iOS 18 release later this year.

Laptop

iOS 18 could bring ‘Hearing Aid Mode’ to AirPods Pro — what you need to know

A report claims that Apple won't release new AirPods Pro earbuds this year, but that the iOS 18 update could add a hearing aid mode for the earbuds.

Tom’s Guide

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Top 3 Biotech Stocks to Anchor Your Portfolio

Amid robust global medicine spending, surging biopharma M&A activity, and technological advancements, the biotech industry is set for significant growth this year and beyond. Given the industry’s bright prospects, top biotech stocks Corcept Therapeutics (CORT), Entrada Therapeutics (TRDA), and Exelixis (EXEL) might be ideal buys now to anchor one’s portfolio.…

TechRadar

Apple tipster says AirPods Pro are getting a new hearing aid mode in iOS 18

Why spend thousands of dollars on a hearing aid if your AirPods Pro can do the same job for considerably less cash?

Top News

Wegovy Approved To Reduce Cardiovascular Risk In Overweight Patients

FDA approves Wegovy label change to reduce cardiovascular risk in overweight patients, a significant advancement in obesity treatment with potential implic...

Investors Business Daily

Novo Nordisk Wins FDA Approval For Obesity Drug, Wegovy, To Cut Cardiovascular Risk

Novo Nordisk said Friday its weight-loss drug gained FDA approval to cut the risk of heart attack and strokes. Novo Nordisk stock dipped.

Barchart

Stocks Slide After U.S. Unemployment Report

The S&P 500 Index ($SPX ) (SPY ) is down -0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stock indexes are lower this afternoon, after the S&P 500 and Nasdaq 100 posted new...

Barchart

After a Morning Rally, Stocks Slide This Afternoon After Digesting the U.S. Unemployment Report

Salon

Throw out these 6 cinnamon products now

The products are sold by several retailers nationwide

1 … 59 60 61 62

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.